Stephen J Kolb Selected Research

Spinal Muscular Atrophy (Progressive Muscular Atrophy)

1/2022	Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen.
1/2021	Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy.
1/2021	Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen.
1/2021	Update on Biomarkers in Spinal Muscular Atrophy.
1/2021	Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMA.
1/2020	Longitudinal natural history of type I spinal muscular atrophy: a critical review.
1/2020	Outcome measures in a cohort of ambulatory adults with spinal muscular atrophy.
4/2019	Current Treatment Options in Neurology-SMA Therapeutics.
1/2019	AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort.
9/2018	Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Kolb Research Topics

Disease

23	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022 - 07/2005
3	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2021 - 08/2012
3	Disease Progression 01/2021 - 12/2017
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 01/2014
2	Spinal Diseases (Disease, Spinal) 02/2006 - 07/2005
2	Muscular Atrophy (Muscle Atrophy) 02/2006 - 07/2005
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Fatigue 01/2021
1	Nausea 01/2021
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2021
1	Rare Diseases (Rare Disease) 12/2017
1	Premature Obstetric Labor (Premature Labor) 11/2017
1	Hearing Loss (Hearing Impairment) 01/2017
1	Muscular Diseases (Myopathy) 01/2017
1	Distal Myopathies (Distal Muscular Dystrophy) 01/2017
1	Hoarseness 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	X-Linked Bulbo-Spinal Atrophy 07/2015
1	Muscle Weakness 03/2015
1	Peripheral Nerve Injuries 08/2012
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 05/2007
1	Frontotemporal Dementia (Semantic Dementia) 05/2007
1	Stroke (Strokes) 01/2003

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2005
4	nusinersenIBA 01/2022 - 01/2021
3	Small Nuclear Ribonucleoproteins (snRNP)IBA 06/2012 - 07/2005
2	Biological ProductsIBA 01/2021 - 03/2016
2	Valproic Acid (Depakote)FDA LinkGeneric 06/2015 - 02/2014
1	Inosine FDA Link 01/2021
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2021
1	NAD (NADH)IBA 01/2021
1	reldesemtivIBA 01/2021
1	neurofilament protein LIBA 01/2021
1	ZolgensmaIBA 01/2019
1	RibonucleoproteinsIBA 01/2018
1	Pharmaceutical PreparationsIBA 12/2017
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2017
1	Antisense OligonucleotidesIBA 03/2016
1	salicylhydroxamic acid (SHAM)IBA 03/2016
1	Hexosaminidase A (Hex A)IBA 07/2015
1	Complement System Proteins (Complement)IBA 07/2015
1	Heavy MetalsIBA 07/2015
1	Monoclonal AntibodiesIBA 01/2014
1	Crystallins (Crystallin)IBA 08/2012
1	Small Heat-Shock ProteinsIBA 08/2012
1	SMN Complex ProteinsIBA 08/2007
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 05/2007
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 05/2007

Therapy/Procedure

9	Therapeutics 01/2021 - 01/2014
1	Cesarean Section (Caesarean Section) 11/2017
1	Subacute Care 01/2003